BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Autoimmunity
,
Quercetin
,
rs2476601
,
FGF21
,
Fatty acid metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tusc2
(gene)
NextBio Summary
General Info
Body Atlas
Most Correlated Tissues
Skeletal muscle psoas
Cerebellum peduncles
Cingulate cortex
Globus pallidus
Pons
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Rhinitis
Injury of eye region
Bacterial infection due to Bacillus
Urogenital injury
Ebola virus disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
epigallocatechin gallate
Terazosin
oxantel
cefepime
LPS 9
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR101-2
MIR101-1
PRNP
IGF2R
FXN
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Mitochondrial protein Fus1/Tusc2 in premature aging and age-related pathologies: critical roles of c…
Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1.
Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.
Fus1/Tusc2 is a novel regulator of mitochondrial calcium handling, Ca2+-coupled mitochondrial proces…
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
TUSC2-nanoparticles and Erlotinib in Stage IV Lung Cancer
TUSC2-nanoparticles (GPX-001) and Osimertinib in Patients With Stage IV Lung Cancer Who Progressed o…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ